Abstract Library

#2929 Type III Gastric Neuroendocrine Neoplasms: Is Local Excision Sufficient in Selected Cases?

Introduction: As per ENETS Guidelines, patients with type III gastric neuroendocrine neoplasms (t-III g-NEN), need to undergo partial or total gastrectomy. Data for less-extensive resections are limited.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Exarchou K

Authors: Exarchou K, Kameniarz L, Tsoli M, Victor A, Oleinikov K,

Keywords: T-III gNEN, EMR, ESD, wedge resection,

#2253 The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-Trend and Outcome Analysis from 587 Consecutive Resections at a High-Volume Institution

Introduction: Reflecting their rarity and heterogeneity, Pan-NENs represent a clinical dilemma and there is a scarcity of data regarding their long-term follow-up after resection.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Marchegiani G

Authors: Marchegiani G, Landoni L, Pollini T, Miotto M, Cingarlini S,

Keywords: Pancreas, Pan-NENs, Surgery, NET,

#2042 The Laparoscopic Approach in the Surgical Treatment of the Gastric Neuroendocrine Tumors

Introduction: The incidence of G-NETs has been increased significantly over the last decades, which seems set to continue. The treatment of gastric NETs comprises a wide range of surgical approaches alone or in combination with chemotherapy and target therapy. Laparoscopic surgery is the reasonable method of choice for the partial stomach resection as well as when the gastrectomy is needed.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Zubaryev M, Kolesnik O, Lukashenko A, Ostapenko Y, Boiko A,

Keywords: gastric neuroendocrine tumors, laparoscopic gastric resection, open gastric surgery,

#1451 Pancreatic NENs <2 cm Could Represent a New Entity Worth of Further Investigation

Introduction: Surgical approach to the treatment of well-differentiated pancreatic neuroendocrine neoplasms (pNENs) is based on tumor size and Ki67. Surgical removal is not recommended for tumors <2cm, due to their indolent nature. Ki67≤2% and size <2cm are considered indicative of benign tumors. However, size and Ki67 may not correctly predict the prognosis of patients with pNENs <2cm.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Milione M

Authors: Milione M, Maisonneuve P, Alessio P, Centonze G, Coppa J,

Keywords: NEN, <2cm, prognosis,

#1427 Uncinatectomy: Rethinking the Surgical Approach for Neuroendocrine and Intraductal Papillary Mucinous Neoplasms of the Pancreas

Introduction: Pancreatic neuroendocrine tumors (pNETs) and intraductal papillary mucinous neoplasms (IPMN) are increasingly recognized pancreatic tumors due to advances in imaging. Standard of care is surgical resection for these tumors is via the appropriate procedure: pancreaticoduodenectomy or enucleation.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Arora A

Authors: Arora A, Scudamore C, Flint J,

Keywords: Pancreatic neuroendocrine tumor, IPMN, uncinatectomy ,